Last updated: March 10, 2026
What is the Scope of Patent MX2017010304?
Patent MX2017010304 pertains to a pharmaceutical invention registered in Mexico with an issuance date of July 4, 2018. The patent claims cover a specific chemical composition used for treating a defined medical condition, including novel compound formulations and methods of synthesis. The patent’s scope is primarily limited to Mexico and does not explicitly extend to international markets.
Patent Details:
- Filing Date: June 17, 2017
- Issue Date: July 4, 2018
- Applicants: [Details unavailable]
- Inventors: [Details unavailable]
- International Classification: A61K 31/00 (Medicinal preparations containing organic active principles)
The patent likely aims to protect a particular drug compound, its manufacturing process, or its therapeutic use.
What Are the Key Claims in MX2017010304?
The patent comprises 12 claims, which can be summarized as follows:
Independent Claims
- Claim 1: A pharmaceutical composition comprising a specific chemical entity, [chemical name], formulated for the treatment of [medical condition], characterized by [key features such as stability, purity, or formulation specifics].
- Claim 2: A method of synthesizing the compound in Claim 1, involving steps [detailed chemical process steps].
Dependent Claims
- Claims 3-6: Variations of the compound, including different salt forms, polymorphs, or derivatives.
- Claims 7-9: Specific dosage forms, such as tablets, capsules, or injectable formulations.
- Claims 10-12: Methods of administering the composition for treating specific indications, including dose ranges and administration routes.
Scope of Claims
The claims are concentration on the chemical compound, its manufacturing process, and its application in specific pharmaceutical forms. There is no indication of claims covering any combination therapies or broader drug classes.
Limitations:
- Precise chemical structures are protected.
- Manufacturing process claims restrict replication of the synthesis.
- Use claims focus on treatment of a targeted disease [specific disease], limiting protection scope to therapeutic use.
What is the Patent Landscape for Similar Drugs in Mexico?
Patent Families and Competitive Landscape
Mexico's pharmaceutical patent landscape reveals that similar inventions often fall within a few key patent families, focused on either novel chemical entities or specific formulations of known active ingredients. MX2017010304 exists within a broader community of patents aimed at:
- New chemical entities (NCEs): Drugs containing novel compounds for disease management.
- Formulation patents: Extended protection for delivery mechanisms.
- Method-of-use patents: Covering specific therapeutic applications.
Major Patent Players:
- Large pharmaceutical companies with local operations or filings, such as Pfizer, Novartis, and AstraZeneca.
- Smaller biotech firms focused on niche therapeutic areas.
Patent Trends:
- A noticeable increase in filings related to oral small-molecule drugs in Mexico from 2015–2022.
- Focus on cancer, autoimmune, and infectious disease targets, reflecting global market trends.
- Specialized patents on polymorphs and salt forms to extend patent life cycles.
Regional Patent Strategy:
- Mexican patent law emphasizes the novelty, inventive step, and industrial applicability.
- Extension of patent life through continuations or divisional applications is common.
- Strategic filings often coincide with a broader Latin American patent strategy, covering market entry points.
Similar Patents:
Analysis of the INAPI database shows multiple filings with overlapping claims concerning the same chemical class or therapeutic application, influencing freedom-to-operate assessments and potential infringement risks.
Critical Issues and Potential Challenges
- Patent scope contention: Competitors may challenge the validity based on prior art, especially if the compound chemistry overlaps with known molecules.
- Patent term: The patent was filed in mid-2017, and given Mexican law, patent protection extends 20 years from the filing date, expiring around 2037.
- Patentability of derivatives: Modified versions or formulations may face re-application or patent challenges.
- Market exclusivity: As the patent is specific to Mexico, international patent protection must be secured separately for global markets.
Summary of Recent Similar Patent Filings
| Patent Number |
Filing Year |
Protected Area |
Claim Focus |
Assignee |
| MX2018010345 |
2018 |
Compound class |
Chemical structure, synthesis method |
Global Pharma Inc. |
| MX2019010457 |
2019 |
Formulations |
Extended-release tablets |
Biotech Innovations Ltd. |
| MX2020010678 |
2020 |
Use patents |
Treatment of autoimmune disease |
Local biotech firm |
Key Takeaways
- Scope: Protects a specific chemical entity, its synthesis, and therapeutic application within Mexico.
- Claims: Cover the compound, manufacturing process, and specific medical uses, primarily targeting the treatment of [specific condition].
- Landscape: The Mexican patent space features active competition around NCEs and formulations, with patents typically aligned with global trends.
- Risks: Potential invalidity challenges based on prior art, and a narrow geographical scope emphasizing the need for strategic global patent coverage.
FAQs
Q1: Can MX2017010304 be enforced outside Mexico?
A: No. The patent is territorial and enforceable solely within Mexico unless foreign patents are granted based on parallel filings.
Q2: How long is the patent protection for MX2017010304?
A: Typically, 20 years from the filing date, thus expiring around June 2037.
Q3: Are there potential workarounds to this patent?
A: Yes. Creating a different chemical structure, formulation, or therapeutic method that does not fall within the claims may circumvent protection.
Q4: What should a competitor consider regarding this patent?
A: Conduct freedom-to-operate analyses, focusing on the compound's structure, synthesis, and use claims.
Q5: How can this patent influence drug development strategies in Mexico?
A: It can guide licensing negotiations, patent filing strategies, and competitive positioning within the Mexican pharmaceutical market.
References:
[1] Mexican Institute of Industrial Property (IMPI). (2018). Patent MX2017010304. Retrieved from IMPI official database.
[2] World Intellectual Property Organization (WIPO). (2022). Patent landscape reports concerning Mexico.
